In contrast to other YB-1 biomarker studies (To et al, 2010), which consider nuclear YB-1 only, we also looked at the cytoplasmic expression in the evaluation of the DSS of grade 2 HNSCC patients. Here, YBX1 is linked to head and neck squamous cell carcinoma.